简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-10-18 10:21 Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
2023-10-18 10:19 Takeda Settles Tax Dispute with Irish Revenue over Break Fee Received by Shire
2023-10-18 09:06 Saudi Fund for Development Signs Additional $20 Million Development Loan Agreement to Fund Infrastructure Projects in the Republic of Central Africa
2023-10-18 08:58 Neu REFIX β-glucan reduces muscle fibrosis in Duchenne muscular dystrophy MDX mice, in joint research with Dr. Yoshitsugu Aoki, NCNP, Tokyo, Japan.
2023-10-17 16:38 MMI Expands Global Footprint with Entry into Asia Pacific Market
2023-10-16 14:15 Merck to Present Latest Research from Oncology Portfolio at ESMO 2023
2023-10-16 09:22 Medisca Takes Additional Steps to Protect Its Innovative Technologies
2023-10-16 09:14 Amylyx Pharmaceuticals Receives Negative CHMP Opinion on its Marketing Authorisation Application for AMX0035 for the Treatment of ALS in the European Union Following Re-Examination Process
2023-10-13 19:36 Galderma Unveils Bold Ambition in Neuromodulation at Liquid Live Event
2023-10-13 09:14 FDA Finds No Misconduct by Care Access in Pfizer’s Lyme Vaccine Trial
2023-10-13 08:55 AstraZeneca Awards Funding to Eight Innovative Research Projects From Early-Career Scientists Around the World in Second R&D Postdoctoral Challenge
2023-10-13 08:43 AI Medical Service Inc. Signs Joint Research Agreement with Leading Vietnamese Medical Institution
2023-10-12 15:19 Immetas Therapeutics and GC Biopharma Announce Research Collaboration to Discover and Develop mRNA Therapeutics to Treat Autoimmune Diseases
2023-10-12 11:00 Empowering Colombia's Future Through Education; ADFD's Commitment to Colombia's Early Childhood Development
2023-10-12 10:22 Galderma @ EADV 2023: Phase III Trials Demonstrate Nemolizumab’s Efficacy and Rapid Onset of Action in Atopic Dermatitis and Prurigo Nodularis
2023-10-12 08:59 SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers
2023-10-12 08:52 Gritgen Therapeutics Launches Commercial GMP Facility in Suzhou, China
2023-10-11 14:55 Evobrutinib, CNS-Penetrant BTKi, Has Shown Sustained Clinical Benefit Up to Five Years in People with RMS
2023-10-11 08:44 Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.
2023-10-10 14:40 Merck Presents New MAVENCLAD® (Cladribine Tablets) Data Highlighting Sustained Reduction in NfLs and Benefit of Early Initiation

Business Wire Weibo

Press Releases

Latest Releases